Society Logo
ME/CFS Australia Ltd
Please click here to donate ME/CFS Australia (SA) Inc
 
 
Facebook
 
ME/CFS AUSTRALIA (SA) INC

Registered Charity 3104

Email:
sacfs@sacfs.asn.au

Mailing address:
PO Box 322,
Modbury North,
South Australia 5092

Office:
Suite 506,
North Terrace House,
19 North Terrace,
Hackney, SA, 5069


Phone:
1300 128 339

Office Hours:
Wednesdays, 11am-3pm

ME/CFS Australia (SA) Inc supports the needs of sufferers of Myalgic Encephalomyelitis, Chronic Fatigue Syndrome and related illnesses. We do this by providing services and information to members.

Disclaimer

ME/CFS Australia (SA) Inc aims to keep members informed of various research projects, diets, medications, therapies, news items, etc. All communication, both verbal and written, is merely to disseminate information and not to make recommendations or directives.

Unless otherwise stated, the views expressed on this Web site are not necessarily the official views of the Society or its Committee and are not simply an endorsement of products or services.

Become a Member
PDF Application Form (PDF, 242KB)
Why become a member?

Trial of therapy for CFS as mitochondrial dysfunction at Columbia

Wednesday 23 November 2011

From ProHealth:

 

Test tubes

Trial of therapy for CFS as mitochondrial dysfunction at Columbia

ProHealth.com November 19, 2011

“As more data are acquired, we and others believe that CFS is actually a metabolic mitochondrial dysfunction resulting in insufficient energy production.”

Researchers at Columbia University will be recruiting soon for a trial of four nutrients that they believe have the potential to support improved mitochondrial energy production in Chronic Fatigue Syndrome (ME/CFS) patients. This 6-month trial of a therapeutic intervention, set to start in February, will be randomized, double blinded, and placebo controlled.

The trial - "Chronic Fatigue Syndrome: Correction of Mitochondrial Dysfunction by Conditioning Exercise and Nutraceutical Therapy" - is now listed in ClinicalTrials.gov (http://clinicaltrials.gov/ct2/show/NCT01471652). It is based on research suggesting that:

  • ME/CFS involves an energy-draining “mitochondrial dysfunction of the brain and skeletal muscle of genetically susceptible individuals,” often preceded by a viral infection.
     
  • “Both patients with mitochondrial disorders and patients with CFS manifest elevated serum lactate levels after exercise, and demonstrate elevated brain cerebrospinal fluid levels and decreased brain glutathione levels on nuclear magnetic resonance (NMR) spectroscopy.”
     
  • Certain nutritional supplements have been beneficial in treating patients with mitochondrial disorders and have improved the clinical conditions of individual CFS patients.
     
  • Therefore, this trial will administer these nutrients to the treatment group:
     
      - Coenzyme Q10,
      - Acetyl-L-carnitine,
      - Alpha-lipoic acid,
      - DHA (docosahexaenoic acid) - an omega-3 fatty acid found in fish & krill oils,
      - And a multivitamin
     
  • The placebo group will receive fake supplements
     
  • Both groups will undertake ‘conditioning’ exercise
     
  • Results will be measured in terms of change in fatigue and other CFS symptoms, tests of cerebrospinal fluid, glutathione and lactate levels in the brain, and more.

The Principal Investigator is Alfred E Slonim, MD, a CFS specialist focused on correcting “metabolic disorders of uncertain origin.”

Contacts for queries regarding the trial are listed at http://clinicaltrials.gov/ct2/show/NCT01471652.

 

The above, with comments, originally appeared here.

 


 

blog comments powered by Disqus
Previous Previous Page